Rates of revision surgery for mesh midurethral sling placement drop dramatically once a surgeon has reached a certain threshold of annual cases, according to results of a new study.
©lenetsnikolai - stock.adobe.com
Rates of revision surgery for mesh midurethral sling placement drop dramatically once a surgeon has reached a certain threshold of annual cases, according to results of a new study. The research, which appears in Obstetrics & Gynecology, looked at how health system factors (surgeons’ annual surgical volume, specialty, and hospital type) affect risk of revision.
For the retrospective population-based cohort, de-identified administrative health data on all hospital visits between 2004 and 2017 from Alberta Health Services in Canada were examined. Using Canadian Classification of Health Intervention codes, the researchers identified women who underwent mesh midurethral sling placement and tracked whether they needed revision surgery, which was the primary outcome of the study. They also recorded exposure including the annual number of midurethral sling procedures performed by a surgeon, surgeon specialty, facility type, patient age, and concomitant prolapse repair.
Of the 21,028 women who received a midurethral sling for urinary incontinence during the 13-year study period, 1,517 underwent a concomitant mesh procedure for pelvic organ prolapse (POP). Those cases were censored from the final dataset, resulting in a sample size of 19,511 women. Mean follow-up for participants was 6.78 ± 3.59 years.
Cumulative rates of revision surgery were 3.84% (95% CI 3.54-4.17) at 5 years and at 10 years the rate increased to 5.26% (95% CI 4.82-5.74). The most vulnerable window for revision was the first year after placement, with 0.40% (95% CI 0.31-0.49) undergoing revision within 30 days and 2.15% (95% CI 1.95-3.52) within 1 year.
Surgeon experience was associated with revision, as was concomitant prolapse surgery. However, after 50 cases per year, odds of revision declined with each additional case (OR 0.99/case, 95% CI 0.98-0.99; OR 0.91/10 cases, 95% CI0.84-0.98). This decline plateaued at 110 cases per year. Surgeon specialty, hospital type, and patient age were not associated with outcome.
The authors note that while revision surgery occurs in just a small proportion of women undergoing midurethral sling placement, the number is not insignificant because each surgery comes with risk. They believe that this study is important because it can help identify ways to reduce risk and patients who might be at increased risk. Furthermore, because the data point to period of time when most repair surgeries occur, physicians may want to pay closer attention to their patients during the first year after sling placement.
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
Study: Pelvic floor dilator reduces pelvic floor muscle injury during vaginal delivery
August 6th 2024A new pilot study published in the International Urogynecology Journal found that Materna Medical’s Prep Device, a pelvic floor dilator, reduced full levator ani muscle avulsion during vaginal delivery in first-time mothers.
Read More
Similar success rates for synthetic and nonsynthetic slings in SUI treatment
July 31st 2024A study found that both synthetic and nonsynthetic slings show similar success rates for treating stress urinary incontinence in women, with synthetic slings demonstrating improved operative outcomes and reduced complications.
Read More
First hysterectomy using miniaturized MIRA Surgical System performed
July 30th 2024Virtual Incision Corporation has announced the successful performance of the first benign hysterectomy using their miniaturized robotic-assisted surgery device, MIRA, in a clinical trial assessing its safety and efficacy.
Read More